Cargando…
Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
In this study, an AQbD-compliant chaotropic chromatography method for ziprasidone and the determination of its five impurities was developed. The influence of critical method parameters (initial and final methanol fraction in the mobile phase, gradient duration) on the set of selected critical metho...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534573/ https://www.ncbi.nlm.nih.gov/pubmed/37765104 http://dx.doi.org/10.3390/ph16091296 |
_version_ | 1785112426404904960 |
---|---|
author | Rmandić, Milena Vasilić, Đorđe Rašević, Marija Zečević, Mira Otašević, Biljana Protić, Ana Malenović, Anđelija |
author_facet | Rmandić, Milena Vasilić, Đorđe Rašević, Marija Zečević, Mira Otašević, Biljana Protić, Ana Malenović, Anđelija |
author_sort | Rmandić, Milena |
collection | PubMed |
description | In this study, an AQbD-compliant chaotropic chromatography method for ziprasidone and the determination of its five impurities was developed. The influence of critical method parameters (initial and final methanol fraction in the mobile phase, gradient duration) on the set of selected critical method attributes (t(_imp. V), t(_imp. V) − t(_imp. I), S and <W(USP)>) was studied by Box–Behnken design. The errors resulting from the calculation of the model coefficients were propagated to the selected responses by Monte Carlo simulations, and their predictive distribution was obtained. The design space was computed (π ≥ 80%), and a working point was selected: initial methanol fraction 38.5%, final methanol fraction 77.5%, and gradient duration 16.25 min. Furthermore, the quantitative robustness of the developed method was tested using the Plackett–Burman design. P(_imp II) and P(_imp V) were found to be significantly affected, the first by mobile phase flow rate and the second by gradient duration. Finally, the method was validated, and its reliability for routine quality control in capsules was confirmed. |
format | Online Article Text |
id | pubmed-10534573 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105345732023-09-29 Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination Rmandić, Milena Vasilić, Đorđe Rašević, Marija Zečević, Mira Otašević, Biljana Protić, Ana Malenović, Anđelija Pharmaceuticals (Basel) Article In this study, an AQbD-compliant chaotropic chromatography method for ziprasidone and the determination of its five impurities was developed. The influence of critical method parameters (initial and final methanol fraction in the mobile phase, gradient duration) on the set of selected critical method attributes (t(_imp. V), t(_imp. V) − t(_imp. I), S and <W(USP)>) was studied by Box–Behnken design. The errors resulting from the calculation of the model coefficients were propagated to the selected responses by Monte Carlo simulations, and their predictive distribution was obtained. The design space was computed (π ≥ 80%), and a working point was selected: initial methanol fraction 38.5%, final methanol fraction 77.5%, and gradient duration 16.25 min. Furthermore, the quantitative robustness of the developed method was tested using the Plackett–Burman design. P(_imp II) and P(_imp V) were found to be significantly affected, the first by mobile phase flow rate and the second by gradient duration. Finally, the method was validated, and its reliability for routine quality control in capsules was confirmed. MDPI 2023-09-14 /pmc/articles/PMC10534573/ /pubmed/37765104 http://dx.doi.org/10.3390/ph16091296 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rmandić, Milena Vasilić, Đorđe Rašević, Marija Zečević, Mira Otašević, Biljana Protić, Ana Malenović, Anđelija Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination |
title | Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination |
title_full | Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination |
title_fullStr | Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination |
title_full_unstemmed | Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination |
title_short | Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination |
title_sort | development of analytical quality by design compliant chaotropic chromatography method for ziprasidone and its five impurities determination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534573/ https://www.ncbi.nlm.nih.gov/pubmed/37765104 http://dx.doi.org/10.3390/ph16091296 |
work_keys_str_mv | AT rmandicmilena developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination AT vasilicđorđe developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination AT rasevicmarija developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination AT zecevicmira developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination AT otasevicbiljana developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination AT proticana developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination AT malenovicanđelija developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination |